Elsevier

European Urology

Volume 54, Issue 6, December 2008, Pages 1354-1362
European Urology

Prostate Cancer
Evaluation of Prostate Cancer Detection with Ultrasound Real-Time Elastography: A Comparison with Step Section Pathological Analysis after Radical Prostatectomy

https://doi.org/10.1016/j.eururo.2008.02.035Get rights and content

Abstract

Background

Conventional gray scale ultrasound has a low sensitivity and specificity for prostate cancer detection. Better imaging modalities are needed.

Objective

To determine sensitivity and specificity for prostate cancer detection with ultrasound-based real-time elastography (elastography) in patients scheduled for radical prostatectomy (RP).

Design, Setting, and Participants

Between July and October 2007, 109 patients with biopsy-proven localized prostate cancer (PCa) underwent elastography before RP. The investigator was blinded to clinical data.

Measurements

A EUB-6500HV ultrasound system with a V53W 7.5 MHz end-fire transrectal probe was used preoperatively. Areas found to be suspicious for PCa were recorded for left and right side of the apex, mid-gland, and base. These findings were correlated with the obtained whole-mount sections after RP.

Results and Limitations

Sensitivity and specificity for detecting PCa were 75.4% and 76.6%, respectively. A total of 439 suspicious areas in elastography were recorded, and 451 cancerous areas were found in the RP specimens. Positive predictive value, negative predictive value, and accuracy for elastography were 87.8%, 59%, and 76%, respectively. Nevertheless, there are limitations to our studies because we investigated specific patients scheduled for RP with apparent PCa. Whether elastography is practical as a diagnostic tool or can be used to target a biopsy and be at least as sensitive in tumor detection as extended biopsy schemes has yet to be determined.

Conclusion

Elastography can detect prostate cancer foci within the prostate with good accuracy and has potential to increase ultrasound-based PCa detection. Further studies need to be done to approve these data and to evaluate whether tumor detection can be increased by elastography-guided biopsies.

Introduction

The use of prostate-specific antigen (PSA) as a diagnostic and screening tool has led to a significant rise in the number of patients undergoing prostate biopsy. However the specificity of the PSA test is low [1], [2]. Furthermore, because of the intensive PSA testing, in recent years prostate tumors have become drastically reduced in size [3] and only a small portion of the prostate is sampled by biopsies. Hence repeat biopsies are often taken; these biopsies have a relatively poor negative predictive value (NPV) with a detection rate of less than 20% [4].

Conventional gray-scale ultrasound has a low sensitivity and specificity for prostate cancer (PCa) detection. It is useful to guide biopsies but insufficient as a screening tool. Thus, an improved imaging modality for PCa detection using targeted biopsies is needed.

Ultrasound-based real-time elastography imaging is a new technique that visualizes the differences in tissue strain produced by freehand compression [5]. Using elastography, the investigator is able to discriminate hard from soft tissue regions within the prostate. The phenomenon is based on the fact that the back-scattered ultrasound signals undergo displacement if the tissue is slightly compressed or decompressed (ie, approximately 2%). Stiffer tissues show less displacement than normal soft tissues (Fig. 1a). For visualization, stiffness values are marked in different colors and are shown in real-time images (Fig. 1b). Following the hypothesis that solid tumors differ in their consistency compared with the adjacent normal tissue, elastography has been investigated as a novel tool for detecting PCa. Promising results have been recently reported in small cohorts [6], [7], [8].

The goal of this study was to assess the value of elastography for localizing PCa in a selected, larger cohort of patients scheduled for radical prostatectomy (RP) by comparing results of the elastogram with PCa foci in whole-mount sections. In addition it was of interest to see whether elastography is feasible in daily routine.

Section snippets

Patients and methods

A prospective, single-institution, single-observer study was carried out. Between July and October 2007, a total of 109 consecutive patients with biopsy-proven PCa scheduled for open retropubic RP underwent elastography by a single investigator at the day of admission to the hospital. The investigator was blinded to all clinical data. B-mode and elastography findings of all patients were recorded for right and left side of the apex, mid-gland, and base. Areas found to be suspicious for PCa were

Results

Overall, 439 suspicious areas were documented for elastography compared with the 451 tumor foci documented by the pathologist. In histopathology the distribution of the tumors was most prominent for the apical region (40%), followed by the mid-gland (33%), and the base of the prostate (26%), without any significant differences between the sides of the gland. The results obtained by elastography did not differ significantly (Table 2,Fig. 2). The histopathological results are summarized in Table 1

Discussion

To date there is no imaging modality for a routine use that can visualize cancerous foci in the prostate with certainty.

Systematic, randomized ultrasound-guided biopsy is the gold standard for PCa detection, because sensitivity and specificity for visualization of PCa foci using gray-scale ultrasound is low. The correlation of a hypoechoic area to cancer falls short, with reported conformities between 17% and 57% [10]. Furthermore, it is suggested that a high proportion of carcinomas in the

Conclusion

Elastography seems to be a good tool to improve PCa detection in ultrasound investigations. At least one tumor focus has been identified in each patient. Whether elastography is practical as a diagnostic tool, or whether it can be used to develop a targeted biopsy scheme that is at least as sensitive in tumor detection as an extended biopsy scheme has yet to be determined.

Cited by (0)

View full text